Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 3,306.10
+58.05 (1.79%)
At close: Jun 16, 2026
Sanofi India Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Sanofi India stock has a consensus rating of "Buy" and an average price target of ₹4,579. The average 1-year stock price forecast is 38.50% higher than the current stock price, while the lowest is ₹3,700 (+11.91%) and the highest is ₹5,550 (+67.87%).
Price Target: ₹4,579 (+38.50%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sanofi India stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Financial Forecast
Revenue This Year
19.51B
from 18.37B
Increased by 6.17%
Revenue Next Year
20.79B
from 19.51B
Increased by 6.58%
EPS This Year
173.50
from 150.56
Increased by 15.24%
EPS Next Year
179.07
from 173.50
Increased by 3.21%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.6B | ||
| Avg | 19.5B | ||
| Low | 19.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.7% | ||
| Avg | 6.2% | ||
| Low | 5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 173.50 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 15.2% | ||
| Low | - |